title: Remission induction with cytarabine and daunorubicin with or without 6-thioguanine in adult patients with acute myelocytic leukemia.
authors.forename: M R
authors.initials: MR
authors.lastname: Nowrousian
authors.forename: R
authors.initials: R
authors.lastname: Pfeiffer
authors.forename: U W
authors.initials: UW
authors.lastname: Schaefer
authors.forename: R
authors.initials: R
authors.lastname: Osieka
authors.forename: N
authors.initials: N
authors.lastname: Niederle
authors.forename: C
authors.initials: C
authors.lastname: Anders
authors.forename: C G
authors.initials: CG
authors.lastname: Schmidt
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D012074:Remission Induction; D013866:Thioguanine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D013866:Thioguanine; D003630:Daunorubicin